Your Triglycerides Won't Budge. Here's the Biological Reason.

Your APOE gene encodes apolipoprotein E, a critical protein that binds to cholesterol and triglyceride-rich particles, helping your liver recognize and remove them from your bloodstream. Think of it as the address label on lipid delivery trucks. Without effective APOE, those trucks circle your blood longer than they should.

The APOE gene comes in three common versions: e2, e3, and e4. You inherit one copy from each parent. The e4 variant, which roughly 25% of people with European ancestry carry at least one copy of, significantly impairs this clearance process. People with the e4 variant show measurably elevated LDL cholesterol and triglycerides, and their bodies struggle to clear these particles efficiently even with aggressive diet changes.

What this feels like: Your triglycerides hover stubbornly in the 200-400 range despite months of carb restriction. Your doctor calls it metabolic dysfunction. Your body is actually just slower at mopping up the fat circulating in your blood. The metabolic machinery is working, but the clearance system is running at partial capacity.

PCSK9 is a regulatory protein that destroys LDL receptors on your liver cells. More receptor destruction means fewer docking stations for LDL particles to bind and exit your bloodstream. Your liver becomes less efficient at clearing cholesterol and triglyceride-carrying particles.

Gain-of-function variants in PCSK9, present in roughly 1-3% of the population, amplify this destruction. These variants cause the liver to destroy LDL receptors faster than normal, leaving fewer receptors available to pull lipid particles from circulation. The result: both LDL cholesterol and triglycerides remain elevated, even when liver function is otherwise normal.

What this feels like: You have familial hypercholesterolemia patterns in your blood work (very high LDL, high triglycerides) without obvious family history of early heart disease. Standard statins don’t move the needle much. Your liver physically cannot clear particles fast enough because there aren’t enough receptors to bind them.

The LDLR gene produces the LDL receptor protein that sits on liver cell surfaces and binds LDL particles, pulling them out of circulation for processing or storage. This is the primary mechanism for clearing cholesterol and triglyceride-rich particles from your blood. When LDLR doesn’t work properly, particles accumulate.

Pathogenic variants in LDLR cause familial hypercholesterolemia, found in roughly 1 in 300 people in the general population. These variants reduce the number of functional LDL receptors or impair their binding ability, leaving triglyceride and cholesterol-rich particles to circulate far longer than they should. If you carry two copies (homozygous FH), the effect is severe. One copy still meaningfully elevates lipids.

What this feels like: Your triglycerides have been high since childhood or young adulthood. Lifestyle measures have minimal impact. Your doctor may mention familial patterns, even if you’re not aware of relatives with early heart disease (FH is underdiagnosed). Standard doses of statins barely budge your numbers.

Apolipoprotein B (ApoB) is the structural scaffold of LDL and VLDL particles. It’s the critical protein that allows those particles to bind to LDL receptors on liver cells and be removed from circulation. Without functional ApoB, particles get made but cannot be efficiently cleared.

Variants like R3527Q in the APOB gene are found in roughly 5% of familial hypercholesterolemia cases and impair the receptor-binding domain of ApoB. This means your liver can produce LDL and triglyceride-carrying particles normally, but those particles cannot efficiently dock at the LDL receptor, so they accumulate in your blood.

What this feels like: You have the lipid profile of familial hypercholesterolemia (very high LDL, elevated triglycerides) but LDLR genetic testing comes back normal. Your particles are well-formed; they just can’t be recognized and cleared by your liver. Diet and exercise change your waistline but barely move your triglycerides.

CETP is a protein that transfers cholesterol esters from HDL (good cholesterol) to VLDL and LDL particles (bad cholesterol). In effect, CETP shifts cholesterol from the particles you want (HDL) to the particles you don’t want (VLDL, triglyceride-rich). Variants that reduce CETP activity preserve more cholesterol in HDL but can paradoxically worsen triglycerides by altering VLDL particle composition.

Variants like TaqIB and I405V in CETP, carried by roughly 40% of the population, reduce CETP protein activity. This elevation in HDL cholesterol can look good on paper, but the trade-off is often smaller, denser VLDL particles that carry more triglycerides per particle and are cleared more slowly from blood.

What this feels like: Your HDL cholesterol is higher than your doctor expects (good sign), but your triglycerides refuse to budge despite that advantage. You may have many small, dense LDL particles on advanced lipid testing, even though your basic LDL number isn’t catastrophic.

Lipoprotein(a) (Lp(a)) is a particle similar to LDL but carrying an additional protein called apolipoprotein(a). Lp(a) is largely genetically determined: your LPA gene variants set your baseline Lp(a) level, and lifestyle changes do almost nothing to lower it. Elevated Lp(a) is an independent cardiovascular risk factor, particularly dangerous in combination with high triglycerides.

Roughly 20% of the population carries genetic variants that produce high Lp(a) levels, often in the 300-500+ mg/dL range. Elevated Lp(a) is sticky and atherosclerotic, meaning it lodges in artery walls and triggers inflammation independent of your LDL or triglyceride levels. It’s especially damaging when combined with elevated triglycerides.

What this feels like: Your triglycerides are elevated, but you also learn (from advanced lipid testing) that your Lp(a) is high. Standard triglyceride medications don’t touch Lp(a). Your cardiovascular risk feels higher than your doctor’s standard risk calculator suggests, and that intuition is correct.